Shionogi Initiates First-Ever Human Study Testing Therapy for Ultra-Rare Jordan’s Syndrome

Expected to conclude in late 2026, the trial will feature 30 patients with Jordan’s syndrome, aged 9-45 years, who will be tested for a 24-week treatment period.:

Source: Neurology Read More